Clinical trial
Intraarterial Verapamil for Neuroprotection in Ischemic Stroke
NCT03347786 is registered in ClinicalTrials.gov with Global Neurosciences Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intraarterial Verapamil for Neuroprotection in Ischemic Stroke
- Lead sponsor
- Global Neurosciences Institute
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- April 20, 2017
- Completion date
- December 31, 2026
- Enrollment
- 60 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.